Epygenix
Clinical trials sponsored by Epygenix, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug shows promise for rare, severe childhood epilepsy Results expected Nov 2026 (estimated)
- New hope for dravet syndrome: phase 3 trial of EPX-100 aims to cut seizures Results expected Apr 2027 (estimated)